Volume : 13, Issue : 07, July – 2026
Title:
RECENT ADVANCES IN LC–MS/MS ANALYSIS: PRINCIPLES, METHOD DEVELOPMENT, VALIDATION, AND APPLICATIONS IN PHARMACEUTICAL AND BIOMEDICAL SCIENCES
Authors :
Chennupati Pavan, Lingeswara Rao Punati, K.Lavanya, O.Ramya Pavani, S.Nandhini, SK.Maheba
Abstract :
Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS) has emerged as one of the most powerful analytical techniques in modern pharmaceutical, clinical, biomedical, environmental, and food sciences. The integration of high-performance liquid chromatography with tandem mass spectrometry combines efficient chromatographic separation with highly selective and sensitive mass detection, enabling accurate qualitative and quantitative analysis of a wide range of compounds in complex biological and environmental matrices. Over the past two decades, significant technological advancements in chromatographic systems, ionization interfaces, mass analyzers, and data-processing software have substantially enhanced the analytical performance of LC–MS/MS. These developments have resulted in improved sensitivity, lower limits of detection and quantification, higher sample throughput, and greater reproducibility.LC–MS/MS has become the preferred analytical platform for bioanalytical method development, pharmacokinetic investigations, bioequivalence studies, therapeutic drug monitoring, metabolomics, proteomics, forensic toxicology, environmental monitoring, and food safety assessment. The technique provides excellent specificity through multiple reaction monitoring (MRM), allowing simultaneous quantification of multiple analytes even at trace concentration levels. Furthermore, recent innovations including ultra-high-performance liquid chromatography (UHPLC), high-resolution mass spectrometry (HRMS), hybrid mass analyzers, microflow chromatography, automated sample preparation, and artificial intelligence-assisted data analysis have further expanded its applications in pharmaceutical research and precision medicine.Recent technological advances and future perspectives are also highlighted to provide researchers, academicians, and pharmaceutical professionals with an updated overview of this rapidly evolving analytical platform.
Keywords: LC–MS/MS, Liquid Chromatography–Tandem Mass Spectrometry, Drug Analysis.
Cite This Article:
Please cite this article in press Lingeswara Rao Punati et al., Recent Advances In Lc–Ms/Ms Analysis: Principles, Method Development, Validation, And Applications In Pharmaceutical And Biomedical Sciences, Indo Am. J. P. Sci, 2026; 13(07).
REFERENCES:
1. Taktode AD, Chaudhari SP, Kotgale NB, Adhao VS. Bioanalytical method development and validation for estimation of active pharmaceutical substance by LC–MS/MS: A general review on bioanalysis. Int J Res Anal Rev. 2024;11(1):69–82.
2. Nikam SR, Patil SA, More DS. Method development, validation, sample preparation, its applications and recent advancement in LC–MS/MS bioanalysis. Asian J Pharm Anal. 2021;11(4):323–331.
3. Kumar KP, Marathakam A, Patnaik S, Kumar S, Sahithi A, Priya DKS, Dogra P. An insight into development and validation of bioanalytical methods for anticancer drugs using LC–MS/MS. Int J Health Sci. 2022;6(S3):6349–6361.
4. Tallam AK, Sahithi A, Nuli MV. A review on bioanalytical method development and validation of anticancer drugs using LC–MS/MS and its applications in routine analysis. J Integral Sci. 2023;6(1):4–19.
5. Dhangude V, Baokar S, Patil R, Rajput M. Bioanalytical method validation of LC–MS/MS assays for trazodone: A critical review based on USFDA and ICH M10 guidelines. J Pharm Res Int. 2026;38(3):36–47.
6. Hefnawy MM, Alanazi MM, Al-Hossaini AM, Alnasser AI, El-Azab AS.LC–MS/MS bioanalytical method for quantification of binimetinib and venetoclax in rat plasma: application to a pharmacokinetic interaction study. Molecules. 2022;28(1):70-79.
7. Nikam SR, Patil SA, More DS. Method development, validation, sample preparation, its applications and recent advancement in LC–MS/MS bioanalysis. Asian J Pharm Anal. 2021;11(4):323–331.
8. Kumar KP, Marathakam A, Patnaik S, Kumar S, Sahithi A, Priya DKS, Dogra P. An insight into development and validation of bioanalytical methods for anticancer drugs using LC–MS/MS. Int J Health Sci. 2022;6(S3):6349–6361.
9. Javid S, Ahmad M, Khan A, et al. Bioanalysis of antihypertensive drugs by LC–MS: Method development, validation and recent advances. Bioanalysis. 2025;17(5):311–332.
10. Wojcik J, Booth B, Stevenson L, et al. 2024 White paper on recent issues in bioanalysis: Three-way cross validation, automated methods and regulatory considerations. Bioanalysis. 2025;17(8):543–596.
11. Parghale R, Patil S, More S, et al. Bioanalytical method validation of rifapentine and 25-desacetyl rifapentine in human plasma using LC–MS/MS. J Appl Pharm Sci. 2025;15(4):1–11.